3D Microtumors from Patient Tissue for Functional Drug Testing

Mechanical tissue dissociation enables the generation of patient-derived microtumors and tissue-derived microtissues that preserve cellular heterogeneity and support reliable functional drug screening.

Generating biologically relevant 3D tumor models from patient tissue remains a major challenge in translational research. In contrast to enzymatic digestion, mechanical dissociation helps preserve the viability of fragile primary cell populations and ECM-associated components, providing a more suitable starting point for functional assays and advanced 3D model workflows.

Why 3D Microtumor Formation is Challenging

Enzymatic dissociation disrupts tissue architecture and breaks down multicellular organization.
Instead of preserving native organization, cells are separated into single-cell suspensions, losing spatial relationships and structural context.
Loss of spatial context can lead to altered cell behavior and reduced physiological relevance.
Once removed from their original environment, cells can change their phenotype and no longer reflect in vivo behavior.
Generating reproducible 3D tumor models and tissue-derived microtissues from primary tissue is difficult and often inconsistent.
Variability in processing methods often leads to inconsistent outcomes in terms of cell viability, composition, and experimental usability.

Mechanical processing offers a gentle and efficient alternative approach that maintains cell viability and supports the formation of functional microtumor systems.

Recent work demonstrates that mechanical dissociation supports the formation of larger, more stable microtumors compared to enzymatic processing, supporting long-term functional assays and drug response studies.

Reference: M. Bouzereau, M. Freitas, J. Kelm, S. Manser, E. Le Rhun, M. Weller, T. Weiss (2025) – Long-term functional drug and immunotherapy screening in immune-competent patient-derived microtissues across brain tumors, Neuro-Oncologys V27, Supplement 5 doi:10.1093/neuronc/noaf201.137

Mechanical dissociation leads to more robust microtumor formation
Instead of loosely aggregated cells, clearly defined and compact structures emerge early during culture.
Microtumors exhibit stable growth over time
Once formed, these structures remain intact and viable, allowing experiments to be followed over extended time periods.
Reduced cell damage compared to enzymatic dissociation
Fewer disrupted cells and debris are observed, resulting in cleaner and more coherent cultures.
Functional responses to drug treatment can be reliably measured
Treatment effects become visible through consistent changes in structure, size, or viability.

Advantages of Automated Mechanical Dissociation for 3D Microtissues and Microtumor Generation

Preservation of viable primary cell populations:
Instead of extensive enzymatic digestion, mechanical dissociation helps preserve fragile primary cells and ECM-associated components as a suitable starting point for downstream microtumor formation.

Formation of stable and uniform microtumors and tissue-derived microtissues:
This results in microtumor structures that form reliably after seeding and show consistent size and morphology across experiments.

Reduced dependency on external stromal support (e.g. astrocytes):
Microtumors can form directly from the patient sample without requiring additional supporting cell types to stabilize the system.

Improved reproducibility compared to enzymatic methods:
By avoiding enzyme-related variability, results become less dependent on timing and batch-to-batch differences.

Compatibility with high-throughput screening platforms:
The workflow integrates naturally into standard plate-based formats, making it suitable for parallelized drug testing.

Maintained cellular heterogeneity and functional relevance:
Viable and diverse tumor cell populations enable more meaningful and representative functional readouts.

Fast and scalable sample processing:
Mechanical dissociation enables rapid and straightforward tissue processing, reducing handling complexity and enabling scalable workflows for larger sample numbers compared to enzymatic digestion.

From Tissue to Functional Microtumor Assay

Collection of tumor tissue (biopsy or resection)
Rapid mechanical dissociation using the TissueGrinder
Seeding into microwell or multiwell plates
Formation of microtumors and microtissues through cellular reorganization
Application of drug compounds
Monitoring of functional responses over time

Automated Mechanical Dissociation enables the generation of:

Compared to conventional 2D culture systems, patient-derived 3D microtumors better preserve clinically relevant tumor characteristics and treatment response dynamics.

These systems are suitable for:

3D Microtumors from Patient Tissue for Functional Drug Testing

Why 3D Microtumor Formation is Challenging

Advantages of Automated Mechanical Dissociation for 3D Microtissues and Microtumor Generation

Compared to conventional 2D culture systems, patient-derived 3D microtumors better preserve clinically relevant tumor characteristics and treatment response dynamics. These systems are suitable for:

Interested in applying mechanical dissociation for microtumor generationg and drug testing?

Compared to conventional 2D culture systems, patient-derived 3D microtumors better preserve clinically relevant tumor characteristics and treatment response dynamics.

These systems are suitable for: